PULM — Pulmatrix, Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1574235 ·
Last close
$1.37
Market Cap
$5.00M
52W High
$4.94
52W Low
$1.06
ADV30
30,378
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -1,221,000 -1,213,000 2,363,000 1,398,000 1,017,000
Jun 2026 0 — -1,046,000 -1,036,000 3,246,000 2,168,000 689,000
Mar 2026 0 — -1,292,000 -1,172,000 4,496,000 3,324,000 905,000
Dec 2025 0 — -908,000 -928,000 4,139,000 4,088,000 329,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-3,910,000
Investing CF
$0
Financing CF
$950,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.27
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-304,526,000
Inventory
—
Receivables
$16,000
ST Investments
—
EBIT TTM
$-4,112,000
Pretax Income TTM
$-4,013,000
Interest Exp TTM
—
Analysts
—

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -5,169,000 -5,162,000 4,139,000 329,000 3,810,000 -5,433,000
Dec 2024 7,806,000 -7,145,000 -9,559,000 9,943,000 996,000 8,947,000 -10,716,000
Dec 2023 7,298,000 -14,740,000 -14,121,000 33,958,000 15,963,000 17,995,000 -15,985,000
Dec 2022 6,071,000 -18,947,000 -18,836,000 40,953,000 9,844,000 31,109,000 -19,356,000
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
$125,000
NetIncome TTM
$-4,013,000
OpCashFlow TTM
—
Assets (Latest)
$3,246,000
Forward EPS
$-4.50

Peers — same industry

TickerNameMarket CapLastDaily %
CDT CDT Equity Inc. $4.93M $0.36 —
CMND Clearmind Medicine Inc. $5.13M $3.45 —
PCSA Processa Pharmaceuticals, Inc. $4.84M $1.73 —
CNSY CERENOME, INC. $4.78M $0.63 —
LTRN Lantern Pharma Inc. $4.67M $0.37 —

News headlines (Yahoo Finance, 1h cache)

Pulmatrix Announces Third Quarter 2026 Financial Results and Progress on Merger
2026-11-17 13:05 · Yahoo
Eos SENOLYTIX’s PTC-2105 Reduced Semaglutide-Associated Lean-Mass Loss in Aged Mice: Data to Be Presented at 19th Sarcopenia, Cachexia & Wasting Disorders International Conference
2026-11-09 13:00 · Yahoo
Pulmatrix Announces Closing of Preferred Stock Transaction as Part of Planned Merger
2026-04-21 12:00 · Yahoo
Pulmatrix Announces First Quarter 2026 Financial Results
2026-05-15 12:20 · Yahoo
Eos SENOLYTIX Reports Interim Data Showing Preserved Physical Function with MitoXcel Geropeptide PTC-2105 in a Second Species, Aged-Rat Study
2026-10-30 12:00 · Yahoo
Eos SENOLYTIX Presents Late-Life Survival and Healthspan Data for Mitochondria-Targeted Geropeptide PTC-2105 at the 17th World Congress on Targeting Mitochondria, and Launches “Team Speedy” to Let the
2026-10-22 12:00 · Yahoo
Eos SENOLYTIX to Highlight Next-Generation Mitochondria-Targeted Therapeutics at 17th World Congress on Targeting Mitochondria
2026-09-22 12:30 · Yahoo
Pulmatrix Announces Second Quarter 2026 Financial Results and Progress on Merger
2026-08-13 12:15 · Yahoo
Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan
2026-03-26 12:00 · Yahoo
Wave crashes on obesity drug update; Kodiak’s reboot pays dividends
2026-03-26 10:46 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.